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Objective: Galvanotaxis, the migratory response of cells in response to electrical stimulation, has been
implicated in development and wound healing. The use of mesenchymal stem cells (MSCs) from the
synovium (synovium-derived stem cells, SDSCs) has been investigated for repair strategies. Expansion of
SDSCs is necessary to achieve clinically relevant cell numbers; however, the effects of culture passage on
their subsequent cartilaginous extracellular matrix production are not well understood.
Methods: Over four passages of SDSCs, we measured the expression of cell surface markers (CD31, CD34,
CD49c, CD73) and assessed their migratory potential in response to applied direct current (DC) electric
ﬁeld. Cells from each passage were also used to form micropellets to assess the degree of cartilage-like
tissue formation.
Results: Expression of CD31, CD34, and CD49c remained constant throughout cell expansion; CD73
showed a transient increase through the ﬁrst two passages. Correspondingly, we observed that early
passage SDSCs exhibit anodal migration when subjected to applied DC electric ﬁeld strength of 6 V/cm.
By passage 3, CD73 expression signiﬁcantly decreased; these cells exhibited cell migration toward the
cathode, as previously observed for terminally differentiated chondrocytes. Only late passage cells (P4)
were capable of developing cartilage-like tissue in micropellet culture.
Conclusions: Our results show cell priming protocols carried out for four passages selectively differen-
tiate stem cells to behave like chondrocytes, both in their motility response to applied electric ﬁeld and
their production of cartilaginous tissue.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage is the connective tissue that lines diarthrodial
joints and serves to bear load and provide low friction and wear
during motion1. When the tissue is damaged through physical
injury or a disease such as osteoarthritis (OA), the healing response
is inadequate due to the avascular nature and limited cellularity of
adult cartilage2. We and others have investigated the use of: C.T. Hung, Department of
sterdam Ave, New York, NY
ternational. Published by Elsevier Lmesenchymal stem cells (MSCs) found in the neighboring syno-
vium, that are known as SDSCs3,4, for the repair of articular carti-
lage. With the addition of appropriate lineage-speciﬁc culture
medium, the population of SDSCs has been conﬁrmed to be multi-
potent, capable of differentiating into several mesenchymal line-
ages, including chondrocytes, osteoblasts, adipocytes, and
myocytes5e7. As such, harvested SDSCs expanded through multiple
passages in vitro in the presence of a chondrogenesis-promoting
growth factor cocktail3,4 have been shown to produce extracel-
lular matrix (ECM) components similar to chondrocytes (i.e.,
collagen II and aggrecan)4,6,8 and to generate material and me-
chanical properties similar to native cartilagewhen encapsulated in
agarose hydrogel3. SDSCs thus represent a promising new source
for cell-based strategies for the repair of articular cartilage.td. All rights reserved.
Fig. 1. Schematic of galvanotaxis setup. Cells seeded on a glass slide were inserted into
a custom chamber and exposed to an electric ﬁeld gradient for three hours.
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is thought to be due, in large part, to insufﬁcient migration to the
damage site by cells that have the potential to repair the lesion9.
Thus, strategies that enhance and direct SDSC migration could
amplify the intrinsic repair process. The use of direct current (DC)
electric ﬁelds (EFs) of strengths ranging from 1 to 10 V/cm is known
to induce directed movement (galvanotaxis) and shape change
(galvanotropism) in a number of musculoskeletal cells including
chondrocytes, ﬁbroblasts, osteoblasts, osteoclasts, and meniscal
ﬁbrochondrocytes10. Endogenously generated EF gradients of this
strength have also been shown to guide cell migration in devel-
oping embryos11 and at the cut surface of wounds12. Hence, gal-
vanotaxis may be a useful tool for encouraging and promoting the
migration of a clinically relevant cell type to sites of articular
cartilage defects.
Stem cells such as SDSCs exhibit phenotypic and behavioral
changes as terminal differentiation is reached. Previously, we
determined via ﬂow cytometry, that changes in cell surface mole-
cules are measurable throughout differentiation; some of these
surface molecules may in fact serve as growth factor receptors or
adhesion molecules that play a direct role in the differentiation
process. Further, it was shown that manipulation of cell surface
charges with chemical modiﬁers such as neuraminidase, an
enzyme that removes sialic acids13, or lectins14, alters EF motility15,
pointing to a strong inﬂuence of surface molecules in directed
migration. Taken together, these results suggest the hypothesis that
differentiating SDSCs exhibit markedly different behavior
depending on culture expansion age.
We are unaware of any previous studies that correlate a change
in cell surface marker expression with a change in migration
response to EF. Furthermore, it is not clear whether cells of a certain
passage are preferentially more likely to adopt a phenotype favor-
able for cartilage matrix development. Thus, in this paper, we
examine the surface markers and migration characteristics of
SDSCs through four passages of culture; we hypothesize that as
SDSCs reach a chondrocytic phenotype, their migration character-
istics begin to resemble those reported for chondrocytes16. In par-
allel, through 3D pellet cultures using cells from each passage, we
attempt to elucidate the passage at which SDSCs exhibit the
greatest potential to synthesize cartilaginous matrix, in order to
optimize their use for tissue-engineered constructs.
Methods and materials
Experimental design
Three controlled and concurrent cell culture studies are
described herein, aimed at characterizing the behavior of juvenile
bovine SDSCs. Speciﬁcally, study one examined the effect of cell
passage number on the expression of four cell surface markers
found on MSCs. Study two characterized the cellular response of
these cells at each passage to an applied DC EF of comparable
magnitude as those found at the cut surface of wounds in order to
identify a cell population most suitable for wound repair. Finally,
study three explored the development of tissue at each passage to
investigate a potential correlation between cell migration behavior
and matrix composition.
Cell isolation and expansion
The intimal layer of the synovium was harvested from bovine
knee joints of four freshly slaughtered 2e4 week old calves, as
described previously3. Medium supplemented with 1 ng/mL TGF-
b1, 5 ng/mL bFGF, and 10 ng/mL PDGF-bb3 was changed every three
days. At conﬂuence, cells were trypsinized and then counted. Onesubset of the cells at each passage was replated for further
expansion, another subset was used for ﬂow cytometry analysis, a
third subset was used for galvanotaxis experiments, and a ﬁnal
subset was used for 3D micropellet culture.Cell surface marker assessment
The phenotype of bovine SDSCs at each passage (P1 to P4) was
assessed by ﬂow cytometry, as previously described17. Cells were
stained with antibodies against CD31 (endothelial cell marker,
Thermo Scientiﬁc), CD34 (hematopoietic cell marker, Abcam), and
mesenchymal markers CD49c (Thermo Scientiﬁc) and CD73 (Bio-
Legend)18,19; positive MSC classiﬁcation requires the absence of
CD31 and CD34 and presence of CD7320, while CD49c is a constant
marker of chondrogenic potential of MSCs, decreasing only in the
presence of TGF-b321,22. Cellular ﬂuorescencewas evaluated using a
FACSCalibur ﬂow cytometer (Becton Dickinson, Franklin Lakes, NJ)
and the resulting data analyzed with FlowJo software (version
9.3.2).Galvanotaxis
After trypsinization, cells were allowed to equilibrate for 1 h
before being plated at 2.65  104 cells/cm2 onto sterile glass slides
(Fisher Scientiﬁc, Pittsburgh, PA) with removable silicone wells. To
investigate the inﬂuence of CD73 on P1 cells, one subset of cells was
exposed to 100 mM 50-(a, b-methylene)diphosphate (APCP)23, a
CD73 inhibitor, during the plating period. After cells were allowed
to attach for 1 h in a 5% CO2 incubator at 37C, the slide was rinsed
with medium to remove any nonadherent cells and placed into a
custom galvanotaxis chamber under aseptic conditions [Fig. 1,
described in Ref. 16].
A power supply (Kiethley Instruments) delivered a current of
3.3mA (6 V/cm EF strength) through the chamber, and experiments
were performed at room temperature for 3 h. Control slides were
treated similarly without EF. Cell migration patterns were captured
every 10 min using an Olympus IX-70 inverted microscope and
digital camera (n ¼ 30e40 cells observed in each ﬁeld of view).Cell migration parameters
The position of each cell was manually tracked via a custom
MATLAB program16,24. Migration direction was quantiﬁed as sin 4,
where 4 is the angle between the x-coordinate axis and the
migration vector, such that sin 4was deﬁned as the value 1 when
4 ¼ 4.71 rad (270), the direction of the cathode. The directional
velocity, deﬁned as the component of the speed directed toward
the negative pole (e.g., Refs. 16,25), was obtained by multiplying a
cell's speed by sin 4.



















Fig. 2. Cell surface marker expression of CD31, CD34, CD49c, and CD73 over culture
passage time in a growth factor cocktail. Each data point represents the mean ± 95% CI
expression of cells from three separate harvests. *P < 0.05 vs P1.
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Following trypsinization at each passage, cells were counted and
0.5 mL each of a 1 106 cell suspension was aliquotted into 1.5 mL
sterile screw-top tubes, formed into pellets by centrifugation, and
cultured for 42 days. Chondrogenic medium26 was supplemented
with 10 ng/mL TGF-b3 (R&D Systems) for the ﬁrst 21 days. At days
14, 28, and 42, micropellet samples were harvested. Medium was
completely removed and one subset of the micropellets was indi-
vidually stored at20C for biochemical assaying (n¼ 5). The other
subset of micropellets was ﬁxed in acid formalin ethanol for
immunohistological analysis.
Micropellet immunohistological analysis
Fixed samples were parafﬁn embedded, sectioned (8 mm thick),
and stained for type I and type II collagen, as previously described27,
with TOTO-3 nuclear counterstaining to visualize collagen net-
works and cells. After staining, slides were coverslipped with Flu-
oroshield (Sigma) and sections were analyzed using an inverted
microscope with an Olympus Fluoview confocal system with dual
wavelengths excitation at 488 and 640 nm. Intensity proﬁles of the
stains were generated from a line drawn through the center of the
pellet and a sixth order smoothing curve (32 neighbors) was
superimposed to capture and characterize distribution proﬁles of
collagen matrix formation.
Micropellet biochemical analysis
Samples were thawed, lyophilized, weighed dry, and digested
for 16 h at 56C in proteinase K (MP Biomedicals) to assess DNA,
glycosaminoglycan (GAG), and collagen content, as described
previously28.
Statistics
All statistical tests were performed in Statistica (Tulsa, OK). Cell
Surface Marker Analysis: Three runs were averaged and presented
as the mean expression ±95% CI. A one-way analysis of variance
(ANOVA) with Tukey's HSD post-hoc test with a ¼ 0.05 and sta-
tistical signiﬁcance set at P  0.05 to compare CD73 expression
across multiple passages. Galvanotaxis: Each data point represents
the mean ± 95% CI of 60e80 samples. A two-way ANOVA with
Tukey's HSD post-hoc test (a ¼ 0.05) was performed on cell speed,
directed velocity, and total displacement for factors of treatment
(applied EF vs control), and passage number to determine signiﬁ-
cance (P < 0.05) of the effect of each factor and also the interaction
of the factors. Chi square tests for linear trendswere used to analyze
the percentage of responding cells migrating in the cathodal di-
rection. Micropellet Biochemical Analysis: Each data point repre-
sents the mean ± 95% CI of ﬁve samples. Groups were examined for
signiﬁcant differences by two-way ANOVA with Tukey's HSD post-
hoc test (a ¼ 0.05), with GAG, DNA, or collagen as the dependent
variables, and passage number as the independent variable. Mul-
tiple correlation analyses were carried out to determine the
dependence of cathodal migration on biochemical composition
(GAG and collagen).
Results
Cell surface marker expression
The expression of cell surface markers in bovine SDSCs from P1
to P4 was evaluated by ﬂow cytometry. Less than 3% of the analyzed
population expressed CD31 or CD34 at any passage. Conversely,CD49c and CD73 were expressed by a signiﬁcant proportion of the
cells. Expression of CD49c (a3 integrin) was stable and high (>93%)
during all passages. However, CD73 expression (ecto-
50nucleotidase, SH3, SH4) showed a net change in expression from
P1 (49.3%) to P4 (27.9%); CD73 expression initially increased from
P1 to P2 (P ¼ 0.0128) and then decreased at P3 and P4
(PP3 ¼ 0.0009, PP4 ¼ 0.0002), relative to P1 [Fig. 2].EF-induced cell realignment and migration
Following exposure to an applied DC EF, the majority of cells
reoriented their long axis perpendicular to the direction of the
ﬁeld; this orientation was not inﬂuenced by passage number
[Fig. 3(a)]. The passage number of the cells, however, did directly
inﬂuence the direction of induced migration. At P1, 85% of cells
migrated primarily toward the positive pole (anode, Fig. 3(c)); by
P4, nearly 70% of SDSCs had changed their direction of migration
and moved toward the negative pole (cathode, Fig. 3(d)). A chi
square test used to detect linear trends showed a signiﬁcant
decrease at each passage in cells migrating toward the anode
[Fig. 4(b), P < 0.0001]. For comparison, control cells showed no
signiﬁcant bias toward either pole at all passages, (57% ± 6.7 toward
the anode, P ¼ 0.13 relative to 50%, Figs. 3(b) and 4(a)).Cell migration parameters: speed and displacement depend on
passage number
At all passages, SDSCs exposed to an applied DC EF traveled
faster and migrated a further net distance than cells expanded
similarly, but not exposed to a ﬁeld (PP1 ¼ 0.0001, PP2 < 0.0001,
PP3 ¼ 0.0012, PP4 < 0.0001, Fig. 5). Throughout passages P1eP4, the
spontaneousmigration displacement for control cells changedwith
passage number, initially increasing at P2 (P < 0.0001), before
decreasing at P3 (P ¼ 0.0007) and P4 (P ¼ 0.0021), relative to P1. In
contrast, spontaneous migration speed (PP1P2 ¼ 0.15;
PP1P3 ¼ 0.42; PP1P4 ¼ 0.57) and directed velocity (PP1P2 ¼ 0.98;
PP1P3 > 0.99; PP1P4 ¼ 0.99) of control cells remained similar to
passage P1. In contrast, for cells exposed to EF, there was a signif-
icant drop in speed (PP1P3 < 0.0001, PP1P4 ¼ 0.0203) and directed
velocity (PP1P3 < 0.0001, PP1P4 < 0.0001) at P3 and P4, relative to
P1. The decreased trend in motility mirrors the decrease in CD73
surface marker expression observed after P2 (P < 0.0001), further
highlighting the possibility of CD73 playing a role in cell migration.
Fig. 3. (a) Representative endpoint (t ¼ 3 h) EF cells with realignment of the long axis perpendicular to the direction of the ﬁeld. Representative micrographs of (b) control cells and
EF cells at (c) P1 and (d) P4. Final cell positions (t ¼ 3 h, images on right of bed) were compared to initial cell positions (images on left) and used to calculate overall displacement,
speed, and directed velocity. Scalebar ¼ 50 mm.
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reduction in cell speed (16.0 ± 2.13 mm/h vs 5.66 ± 1.13 mm/h) was
noted (n ¼ 60 cells/group, P < 0.0001).
Tissue development depends on passage number
ECM development from SDSC pellet culture was increasingly
dependent on the extent to which cells had been expanded in a
growth factor cocktail and the corresponding passage number.
Pellets comprised of early passage cells (P1) elaborated signiﬁcantly














Fig. 4. Percentage of cells migrating toward the anode (positive pole) and the cathode (ne
across all passages. (b) EF cells signiﬁcantly changed direction with increasing passage. *Ppassage cells (P4) by day 28 (16.3 ± 1.89%/dw vs 10.5 ± 1.20%/dw,
P < 0.0001) and this trend was consistent for day 42 (20.2 ± 3.64%/
dw vs 7.35 ± 0.85%/dw, P < 0.0001, Fig. 6(a)). In fact, P1 pellets
appeared to continue elaborating GAG following day 28, while P4
pellets began losing GAG content. In comparison, an opposing trend
was noticed with collagen content; P4 pellets showed signiﬁcantly
increased amounts of collagen at all timepoints starting at day 14
relative to P1 pellets (day 14: 52.2 ± 7.49%/dw vs 11.2 ± 2.77%/dw
(P < 0.0001); day 28: 43.5 ± 8.65%/dw vs 24.2 ± 4.33%/dw
(P < 0.0001); day 42: 67.5 ± 8.56%/dw vs 27.1 ± 4.50%/dw















gative pole). (a) Control cells showed no signiﬁcant difference in migration direction
< 0.0001.
Fig. 5. Migration data from galvanotaxis studies performed for 3 h. n ¼ 60e90 cells/
run. *P < 0.05 vs P1; #P < 0.05 vs control.
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Immunohistochemical staining revealed that collagen II depo-
sition was more elaborate and consistent in P4 pellets than P1
pellets [Fig. 7(f) vs Fig. 7(b)]. Histograms of the gray value signal
were constructed to quantify the distribution of the signal intensity



















Fig. 6. Biochemical content [(a) GAG/dry wt and (b) COL/dry wt] of SDSC pellenonhomogenous sinusoidal distribution of the signal intensity
corresponding to the presence of collagen ﬁbers initially at P1
[Fig. 7(d)] that ﬁlls in with increasing passage number to P4. The
maintenance of signal intensity at an elevated gray value across the
pellet conﬁrms homogeneous distribution of collagen ﬁbers
[Fig. 7(h)]. Collagen I deposition was localized mainly to the pe-
riphery of all pellets [Fig. 7(a), (e)], evidenced by the increased
signal intensity at the edges of the histogram, though was
increasingly consistent for P4 pellets compared to their early
counterparts [Fig. 7(g) vs Fig. 7(c)].
Chondrogenic phenotype correlates with cathodal migration
To understand the degree of association between biochemical
constituents (GAG and collagen) elaborated by cells at each passage
in pellet culture and the propensity of these same cells to migrate
toward the cathode, a correlation analysis was performed. The re-
sults of this analysis show that GAG and collagen content can be
useful predictors of cathodal migration potential (r2GAG ¼ 0.86,
P ¼ 0.07; r2COL ¼ 0.92, P ¼ 0.04). When these two factors are taken
in combination (i.e., multiple correlation), a strong signiﬁcant cor-
relation is found (r2 ¼ 0.96, P ¼ 0.02).
Discussion
Previous studies examining passage-dependent changes to stem
cell chondrogenesis have yielded mixed results; some studies have
reported a maintenance of the chondrogenic potential in stem cells
through multiple passages as high as 2029, or even an increase in
gene expression for positive markers of chondrogenesis (COL2A1
and AGC1) from early (P4) to late (P9) passages in adipose-derived
stem cells30. More often, studies have reported a decrease in
chondrogenic potential with increased passage number31e34,
though in these studies, early passage was deﬁned as cells that had
undergone 3e5 trypsinizations. For comparison, our use of SDSCs
through P4 falls within the timeframe reported to be high in
chondrogenic potential, though there has been limited work
exploring these nascent passages. To our knowledge, this is the ﬁrst
study to characterize the changing surface marker expression and
migration pattern of SDSCs over time in culture through these 4
passages when chondrogenic potential is greatest. We have re-
ported here that at early passages (P1, P2), cultured SDSCs exhibit
anodal migration under EF strengths previously used to elicit gal-
vanotaxis in chondrocytes. SDSCs switch their direction of migra-
tion on the same timescale, moving preferentially toward the
cathode, just as permanently differentiated chondrocytes do.
SDSCs show considerable plasticity over extended passages; this
plasticity is sufﬁcient to change their migration direction in



















ts from cells at different passages. n ¼ 5 pellets/group, *PP4 < 0.05 vs P1.
Fig. 7. Immunohistochemical stains of collagen I (a, e) and collagen II (b, f) for pellets comprised of P1 (top row) and P4 (bottom row) expanded cells. Histogram of the intensity
proﬁles (c, d, g, h) through the center of the pellet reveal localized distribution patterns for each matrix component. Scalebar ¼ 200 mm.
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First, migration changes may be attributable to an altered differ-
entiation state. During cell culture, SDSCs are exposed to a growth
factor cocktail comprised of cytokines known to be responsible for
driving differentiation or redifferentiation of cells toward a
chondrocyte-like state3. In particular, progressive differentiation of
the SDSCs can mediate not only changes in simple physical pa-
rameters of the culture but, as we show here, also expression of cell
surface molecules.
Previous studies found that early passage MSCs share morpho-
logical characteristics with ﬁbroblasts (elongated, ﬂat cells35).
Further, both express N-cadherin and neural cell adhesion mole-
cules (N-CAM)36, key regulators of cellecell interaction and cell
migration37. Additional exposure to growth factors brings about a
chondrocyte differentiation process marked by distinct changes in
cell morphology. Cells convert to a more spherical shape thatunderlies varying physical traits known to inﬂuence motility. We
also note that in late passage SDSCs, actin ﬁlaments appear dense
and contracted, which may limit mobility and active migration.
Alternatively, extended exposure to the growth factor cocktail may
induce molecular changes to the cell surface of the differentiating
cells. Indeed, ﬂow cytometry revealed changes in surface mole-
cules, although determining the role of CD73 and/or other candi-
date surface markers in mediating the EF responses will require
further systematic study.
Expression of surface-associated proteins of chondrocytes (e.g.,
collagen II, keratin, sulfated proteoglycans) that are shed into the
ECM surrounding the cells also increases with further expansion17.
Changes in surface charge may be mediated by these surface-
associated proteins, causing the cells to respond differently to the
applied EF. Regulation of speciﬁc surface proteins can also change
motility in EF-exposed cells. For example, the application of EF may
A.R. Tan et al. / Osteoarthritis and Cartilage 23 (2015) 319e327 325regulate and change the concentration of various ECM receptors for
collagen and ﬁbronectin, such as the a2b1 integrin, which has been
reported to be crucial for cell migration38; these receptors polarize
the integrin and its downstream effector RhoA to inﬂuence direc-
tionality of migration39.
The altered migratory patterns we measured in SDSCs are likely
to be initiated through changes in expression of cell surface
markers, which accompanies increasing passages.We observed one
such change, namely, a signiﬁcant increase followed by decrease in
the CD73 marker for stem cell expression. This initial increase in
CD73 expression has previously been seen in mesenchymal stem
cells derived from the synovium following P140, and other studies
have reported a decrease in CD73 expression during
chondrogenesis41e43. This may be due in part to regulation of CD73
by cytokines and growth factors, such as TGF-b43. In addition to
bolstering our previous hypothesis that the cells have adopted a
more chondrocyte-like phenotype in P4 than in P1, these obser-
vations raise the possibility that CD73 or ecto-50-nucleotidase, an
enzyme that catalyzes the conversion of extracellular nucleotides
to adenosine, plays a direct role in mounting a motility response to
EF. Indeed, the observed motility decreases from P1eP4 support
reports implicating CD73 in directly regulating cell migration44. The
results observed for P1 cells exposed to CD73 inhibitor further
reinforce this.
Additionally, exogenously delivered factors such as bFGF45 and
PDGF-bb46 have been found to modulate cell migration, perhaps as
direct chemokinetic factors, similar to the roles of receptors for
epidermal growth factor and hepatocyte growth factor during tu-
mor invasion47. Alternatively, components of the growth may alter
motility via their capacity to upregulate the extracellular-signal-
regulated kinase (ERK) and p38 mitogen-activated kinase (MAPK)
signaling pathways48. In fact, upregulation of the isoform 4MAPK-1
protein has been shown for cells expanded in the same growth-
factor cocktail as described here (ratio[SDSC Primed/SDSC
Unprimed] ~2.417). In keratinocytes and neutrophils, rapid and
sustained phosphorylation of ERK, MAPK and Src is also a direct
consequence of exposure to EF49. In fact, activated Src kinase po-
larizes in the migration direction and recruits phosphatidylinositol
3,4,5-triphosphate (PIP3) to the leading edge of the cell, and targets
the tumor suppressor phosphatase and tensin homologue (PTEN)
to the lateral and back edges.
Although the primary responder(s) to the EF are still unknown,
the PIP3 and PTEN redistributions are mediated by the Phosphati-
dylinositol 3-OH kinase-g (PI(3)Kg) pathway and its upstream ac-
tivators, receptor tyrosine kinases (RTK)49. As such, it is reasonable
to expect cells at different passages, which have been exposed to
increased lengths of time of growth factor and binding to RTKs, will
also exhibit varying responses to the applied EF. For example, an
alteration or attenuation in the distribution of PIP3 and PTEN that is
caused by altered growth factor exposure could shift the cells'
migration direction. Taken together, previous studies, along with
results presented here, point to the likelihood for growth factor
priming and expansion to alter the behavior and response of the
cells to external stimuli.
Late passage cells reveal the capacity to create cartilaginous-like
tissue with increased expression of GAG and collagen by day 42.
Surprisingly, however, these cells exhibited stunted GAG deposition
that may be due to the abundance of elaborated collagen that, for
the ﬁrst time, nears native levels (~60e70%/dry weight). This in-
verse relationship between GAG and collagen quantities follows
trends noted previously for engineered cartilage50. Conﬁrmation of
the presence of type II collagen at P4, the form predominantly
found in articular cartilage, via immunohistological staining further
suggests that only after multiple passages do cells possess a
phenotype that resembles chondrocytes. Furthermore, from thesigniﬁcantly strong correlation between collagen content and
chondrocyte-like migration behavior (movement toward the
cathode), we speculate that collagen II receptors and their associ-
ated a10b1 integrins may be directly involved in directed
movement.
There are some limitations to consider. First, in our studies,
bovine SDSCs from skeletally immature animals were used, as they
are readily available and well characterized. While their use facil-
itates comparisons of our current ﬁndings to our earlier work with
juvenile bovine SDSCs3 and chondrocytes16, it is unclear if an older
population of cells would respond similarly to exogenous cues. In
wound conditions, it is also likely that a cytokine-rich environment
would impart additional chemical factors that also could alter a
cell's behaviors.
Nevertheless, our results show, for the ﬁrst time, that the
response of SDSCs to an applied DC EF is dependent upon the
number of passages used to expand the cells in culture. Further-
more, the change in directionality that the cells exhibit, i.e., their
migration toward opposite poles, is unique and has not been pre-
viously reported. A deﬁnitive characterization of SDSCs throughout
the passages used to expand them may provide insights that will
allow for optimization of their in vivo use in repair strategies.
Ongoing work in the lab has begun characterizing the use of human
bone marrow derived stem cells as well as human SDSCs for
engineered cartilage in pellet culture. This progress, in addition to
parallel studies examining the migratory potential of those cells,
may further our understanding of how therapeutic modulation of
exogenously applied EF can be used to accelerate and control cell
migration during wound healing. Further studies are necessary,
however, to elucidate the mechanism(s) behind the change in
directionality of passaged SDSCs and to identify methods to control
the motility process.
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